tm logo
CRG PREMIERE
Live/Pending
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER

record initialized not assigned to examiner

on 12 Sep 2024

Last Applicant/ Owned by

Suite 2500

Houston

TX

77002

Serial Number

98747364 filed on 12th Sep 2024

Registration Number

N/A

Correspondent Address

Shane Percival

Shane Percival Neugeboren O'Dowd PC

Suite 220

Louisville, CO 80027

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

CRG PREMIERE

Financial Services, namely, providing debt and equity financing to biopharmaceutical, biotechnology, healthcare, drug delivery, healthcare diagnostic, and medical device companies; Investment advisory services; Financial services, namely, providing structured financing for intellectual property assets, namely, revenue streams from patents, trademarks, and trade secrets; Financial services, namely, Read More

Classification Information


Class [036]
Insurance & Financial Services


Financial Services, namely, providing debt and equity financing to biopharmaceutical, biotechnology, healthcare, drug delivery, healthcare diagnostic, and medical device companies; Investment advisory services; Financial services, namely, providing structured financing for intellectual property assets, namely, revenue streams from patents, trademarks, and trade secrets; Financial services, namely, providing structured financing to ownership entities of intellectual property assets, namely, corporations, research institutions, and inventors; Financial investment in intellectual property assets, namely, the licensing of, and purchasing an ownership interest in, revenue streams from patents, trademarks, and trade secrets; Financial investment in assets protected by intellectual property, namely, the licensing of, and purchasing an ownership interest in, revenue-streams from intellectual property protected assets; Financial services, namely, the formation and management of pool investment vehicles and investment accounts for the purpose of investment in debt and equity interests in biopharmaceutical companies, biotechnology companies, healthcare companies, drug delivery companies, healthcare diagnostic companies, medical device companies, and intellectual property assets, namely, revenue streams from patents, trademarks, and trade secrets.


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 98747364

Mark Type

No Service Mark

Attorney Docket Number

No 9000.307.US

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Status DateAction Taken
12th Sep 2024NEW APPLICATION ENTERED